Trial Profile
Efficacy of pneumococcal conjugate vaccine in preventing acquisition and carriage of pneumococcal vaccine serotypes in Tanzanian children withhuman immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; DTaP poliovirus vaccine; Hib vaccine conjugate
- Indications Diphtheria; Haemophilus infections; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 16 Aug 2011 New trial record